Prostate Cancer
Family history of prostate cancer in a Black population - Abstract
September 24, 2012
Validity of the recorded codes of gonadotropin-releasing hormone agonist treatment and orchiectomies in the Danish National Patient Registry - Abstract
September 24, 2012
Diabetic nephropathy is associated with prostate-specific antigen levels in type 2 diabetes mellitus - Abstract
September 24, 2012
The impact of prostate biopsy on urinary symptoms, erectile function, and anxiety - Abstract
September 21, 2012
20-Year survival after radical prostatectomy as initial treatment for cT3 prostate cancer - Abstract
September 21, 2012
Comparative cost-effectiveness of stereotactic body radiation therapy versus intensity-modulated and proton radiation therapy for localized prostate cancer - Abstract
September 21, 2012
Review of hypofractionated radiotherapy for prostate cancer - Abstract
September 21, 2012
Treatment-induced bone loss and fractures in cancer patients undergoing hormone ablation therapy: Efficacy and safety of denosumab - Abstract
September 21, 2012
Quality of life after intensity-modulated radiotherapy for prostate cancer with a hydrogel spacer: Matched-pair analysis - Abstract
September 21, 2012
HPV persistence and its oncogenic role in prostate tumors - Abstract
September 21, 2012
Prostate cancer in African American men: Making awareness a priority, a community-based effort
September 20, 2012
Author Andrea King Colliers adds humor and a woman’s perspective to men's health issues
September 20, 2012
Prostate Education Program (PEP): Inspired pep talks from the Black Barbershop Health Outreach Program Advocate, Stanley K. Frencher, MD, MPH
September 20, 2012
Charlie Wilson brings the message home: “Don’t be afraid to talk about prostate cancer.”
September 20, 2012
Paclitaxel-loaded iron platinum stealth immunomicelles are potent MRI imaging agents that prevent prostate cancer growth in a PSMA-dependent manner - Abstract
September 20, 2012